HTG Molecular Diagnostics, Inc
HTGMDelisted Jul 10, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001169987
HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in HTG Molecular Diagnostics, Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
HTGM is no longer listed, and 13F filings after Q1 2023 list far fewer holders. See Q1 2023
- Institutional holders
- 0
- −12 vs. Q1 2023
- Shares held
- 0
- −24.9K (−100.0%) vs. Q1 2023
- Total value
- $0
- −$67.3K (−100.0%) vs. Q1 2023
- New holders
- 0
- 0 more added
- Sold out
- 12
- 0 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HTGM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 12 | $67.3K |
| Q4 2022 | 10 | $66.2K |
| Q3 2022 | 19 | $283.0K |
| Q2 2022 | 22 | $622.0K |
| Q1 2022 | 22 | $3.19M |
| Q4 2021 | 23 | $14.5M |
| Q3 2021 | 23 | $16.4M |
| Q2 2021 | 25 | $19.7M |
| Q1 2021 | 23 | $11.2M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding HTG Molecular Diagnostics, Inc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 0 | $0 | 0.00% | −14,692−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,198−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,481−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −1,289−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −884−100.0% | Sold out |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −580−100.0% | Sold out |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −279−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −10−100.0% | Sold out |